350 related articles for article (PubMed ID: 34381495)
1. Inflammation and kidney involvement in human viral diseases caused by SARS-CoV-2, HIV, HCV and HBV.
da Mata GF; Fernandes DE; Luciano EP; Sales GTM; Riguetti MTP; Kirsztajn GM
J Venom Anim Toxins Incl Trop Dis; 2021; 27():e20200154. PubMed ID: 34381495
[TBL] [Abstract][Full Text] [Related]
2. Renal Manifestations of Covid-19: Physiology and Pathophysiology.
Armaly Z; Kinaneh S; Skorecki K
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33804075
[TBL] [Abstract][Full Text] [Related]
3. A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results.
Pecly IMD; Azevedo RB; Muxfeldt ES; Botelho BG; Albuquerque GG; Diniz PHP; Silva R; Rodrigues CIS
J Bras Nefrol; 2021; 43(4):551-571. PubMed ID: 34057983
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Toll-like receptor 4 and Interleukin-1 receptor prevent SARS-CoV-2 mediated kidney injury.
Nakazawa D; Takeda Y; Kanda M; Tomaru U; Ogawa H; Kudo T; Shiratori-Aso S; Watanabe-Kusunoki K; Ueda Y; Miyoshi A; Hattanda F; Nishio S; Uozumi R; Ishizu A; Atsumi T
Cell Death Discov; 2023 Aug; 9(1):293. PubMed ID: 37563112
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
6. BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes.
Kalejaiye TD; Bhattacharya R; Burt MA; Travieso T; Okafor AE; Mou X; Blasi M; Musah S
bioRxiv; 2021 Nov; ():. PubMed ID: 34816259
[TBL] [Abstract][Full Text] [Related]
7. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
8. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
[TBL] [Abstract][Full Text] [Related]
9. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
10. Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein.
Pacciarini F; Ghezzi S; Canducci F; Sims A; Sampaolo M; Ferioli E; Clementi M; Poli G; Conaldi PG; Baric R; Vicenzi E
J Virol; 2008 Jun; 82(11):5137-44. PubMed ID: 18367528
[TBL] [Abstract][Full Text] [Related]
11. Kidney injury in COVID-19 patients, drug development and their renal complications: Review study.
Mohamadi Yarijani Z; Najafi H
Biomed Pharmacother; 2021 Oct; 142():111966. PubMed ID: 34333286
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
14. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1.
Kandhaya-Pillai R; Yang X; Tchkonia T; Martin GM; Kirkland JL; Oshima J
Aging Cell; 2022 Jun; 21(6):e13646. PubMed ID: 35645319
[TBL] [Abstract][Full Text] [Related]
15. IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection.
Pérez A; Torregrosa I; D'Marco L; Juan I; Terradez L; Solís MÁ; Moncho F; Carda-Batalla C; Forner MJ; Gorriz JL
Viruses; 2021 Mar; 13(4):. PubMed ID: 33807151
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study.
Liu R; Zhao L; Cheng X; Han H; Li C; Li D; Liu A; Gao G; Zhou F; Liu F; Jiang Y; Zhu C; Xia Y
Liver Int; 2021 Apr; 41(4):720-730. PubMed ID: 33351265
[TBL] [Abstract][Full Text] [Related]
17. Renal Involvement in Pediatric Patients with COVID-19: An Up-to-date Review.
Campos YM; Drumond ALV; de Matos Gamonal M; Parreira MP; Simões E Silva AC
Curr Pediatr Rev; 2021; 17(4):253-263. PubMed ID: 34561986
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
Chatterjee SK; Saha S; Munoz MNM
Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
Norooznezhad AH; Mansouri K
Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
[TBL] [Abstract][Full Text] [Related]
20. Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis.
Albini A; Calabrone L; Carlini V; Benedetto N; Lombardo M; Bruno A; Noonan DM
Front Immunol; 2021; 12():718136. PubMed ID: 34646263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
